South Korea's breakthrough therapy system, Global Innovative Products Fast Track, kicks off with Roche’s follicular lymphoma drug becoming the first to test the new system. Meanwhile, a state-run group is linking with pharma firms to rapidly bring in global new drugs.
GIFT forms Part Of Korea’s Recent Regulatory reforms • Source: Shutterstock
South Korea's regulatory authorities are making diverse efforts to enable the more rapid introduction of novel therapies to the country. as part of a broad goal of improving patients’ access to medical innovation.
As part of this, the Ministry of Food and Drug Safety (MFDS) has now selected Roche Holding AG’s Lunsumio...
